NCT00051038已完成2 期
A Phase II Study of the Safety and Efficacy of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients Who Have Hepatitis B Viremia While Being Treated With Lamivudine
Bristol-Myers Squibb5 个研究点 分布在 1 个国家开始时间: 2002年9月最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 试验地点
- 5
研究概览
简要总结
The purpose of this clinical research study is to assess the safety and effectiveness of entecavir, when being added to lamivudine, in the treatment of adults with chronic hepatitis B infection who are co-infected with HIV.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 16 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (5)
Loading locations...
相似试验
已完成
2 期
Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir TrialsHepatitis B VirusHBVNCT01438424Bristol-Myers Squibb1,053
已完成
3 期
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E AntigenChronic Hepatitis BNCT00035633Bristol-Myers Squibb
进行中（未招募）
2 期
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract MalignanciesGastrointestinal Tract MalignanciesNCT05329766Arcus Biosciences, Inc.332
进行中（未招募）
不适用
Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic AneurysmsAbdominal Aortic Aneurysm (AAA)NCT02009644Bolton Medical158
终止
2 期
Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast CancerBreast CancerNCT05163223Aston Sci. Inc.10